Rib and vertebral bone fibrous dysplasia in a child with tuberous sclerosis complex
- 14 July 2015
- journal article
- case report
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 167 (11) , 2755-2757
Abstract
Tuberous sclerosis complex (TSC) is an autosomal dominant genetic disorder characterized by benign hamartomas in multiple organ systems, primarily the skin, brain, heart, kidneys, lungs, and eyes. The skeletal system is commonly affected in patients with TSC, but these bone lesions are generally asymptomatic and have not been well characterized. We present clinically significant bone growth in two ribs and vertebrae in an 8‐year‐old male patient with TSC and discuss the effects of mammalian target of rapamycin (mTOR) inhibitors as a possible treatment for these osseous abnormalities. This report suggests that skeletal lesions may hold more clinical significance than previously assumed and that further research should be directed toward understanding bone involvement in TSC.Keywords
Funding Information
- Herscot Center for TSC, Massachusetts General Hospital
This publication has 7 references indexed in Scilit:
- Tuberous Sclerosis Complex Diagnostic Criteria Update: Recommendations of the 2012 International Tuberous Sclerosis Complex Consensus ConferencePediatric Neurology, 2013
- mTOR Inhibitors in Tuberous Sclerosis ComplexCurrent Neuropharmacology, 2012
- Tuberous Sclerosis Complex2010
- CT of Sclerotic Bone Lesions: Imaging Features Differentiating Tuberous Sclerosis Complex with Lymphangioleiomyomatosis from Sporadic LymphangioleiomymatosisRadiology, 2010
- Tuberous Sclerosis Complex: A ReviewJournal of Pediatric Health Care, 2007
- Fibrous Dysplasia Involving the Base of the SkullAmerican Journal of Roentgenology, 2002
- Fibrous Dysplasia in a Patient With Tuberous SclerosisJournal of Child Neurology, 1988